This concept is supported by transcriptomic analyses showing that glioma cells, including primary GBM and established cell lines, express a mesenchymal signature comparable to TGF-β-induced EMT in epithelial tumors (34). This evidence concerns the gene TGFB1 and central nervous system cancer.